What Happens If You Skip Hydrocortisone

What Cortisol Actually Does in Your Body

Cortisol is a glucocorticoid hormone produced by the adrenal cortex under direction of the hypothalamic-pituitary-adrenal (HPA) axis. It is not simply a "stress hormone." Cortisol regulates hepatic gluconeogenesis, maintains vascular tone, modulates the immune system, and supports normal cardiac output. Without adequate cortisol, blood vessels lose their ability to constrict, blood sugar drops, and the inflammatory response becomes unregulated.

The adrenal glands normally produce 5 to 10 mg of cortisol per square meter of body surface area daily, peaking between 6:00 and 8:00 AM and reaching a nadir around midnight [1]. This circadian rhythm governs energy, alertness, and immune surveillance. When exogenous hydrocortisone replaces this endogenous production, skipping a dose means your body has zero cortisol supply during that window. Healthy individuals can upregulate production within minutes through ACTH signaling. Patients with adrenal insufficiency cannot.

The Endocrine Society's 2016 clinical practice guideline for primary adrenal insufficiency recommends hydrocortisone at 15 to 25 mg per day, divided into two or three doses, with the largest dose given upon waking to mimic the natural cortisol peak [2]. The reason for split dosing is that hydrocortisone has a plasma half-life of only 90 minutes. Miss one dose and you may have near-zero circulating cortisol for hours.

The Immediate Consequences of a Missed Dose

Within 4 to 6 hours of a missed morning dose, cortisol-dependent patients often notice fatigue, mild nausea, and muscle weakness. These symptoms reflect falling blood glucose and dropping vascular tone. The severity depends on residual adrenal function, which varies.

Some patients with secondary adrenal insufficiency retain partial cortisol secretion and tolerate a single skipped dose without crisis. Patients with primary adrenal insufficiency (Addison's disease) or bilateral adrenalectomy have no residual production whatsoever. For these patients, a missed dose is not a minor inconvenience. A 2015 analysis from the European Adrenal Insufficiency Registry found that the most common trigger for adrenal crisis was gastrointestinal illness preventing oral medication absorption, followed by deliberate or accidental dose omission [3]. The reported incidence of adrenal crisis in primary adrenal insufficiency ranges from 6 to 8 events per 100 patient-years [4].

Symptoms of an impending crisis include severe hypotension, vomiting, abdominal pain, confusion, and loss of consciousness. Without treatment, circulatory collapse and death can follow. The mortality rate per adrenal crisis episode is approximately 6%, according to a German registry study of 444 patients with chronic adrenal insufficiency [5].

Why Stress Makes Skipped Doses More Dangerous

Under physiological stress, healthy adrenal glands increase cortisol output by 2- to 10-fold. Surgery, infection with fever above 38°C, and major trauma each demand a surge that adrenal-insufficient patients cannot produce.

The concept of "stress dosing" or "sick day rules" exists precisely for this reason. The Endocrine Society guideline recommends doubling the oral hydrocortisone dose for minor febrile illness, and administering 50 to 100 mg hydrocortisone intravenously or intramuscularly for surgical procedures or severe illness [2]. A patient who skips a regular dose while simultaneously fighting a gastrointestinal virus faces a double deficit: no baseline replacement and no stress-dose augmentation.

A practical decision framework for missed-dose response:

• Missed dose, no illness, less than 2 hours late: Take the dose immediately. Resume normal schedule.
• Missed dose, no illness, more than 2 hours late: Take the missed dose now. Shift subsequent doses to maintain spacing, or skip only if the next dose is within 1 hour.
• Missed dose during mild illness (low-grade fever, cold): Take double the next scheduled dose. Contact your prescriber within 24 hours.
• Missed dose during vomiting or inability to keep pills down: Administer emergency intramuscular hydrocortisone 100 mg injection from your crisis kit. Seek emergency care.
• Missed dose with symptoms of crisis (severe hypotension, confusion, collapse): Administer IM injection immediately. Call emergency services.

Every patient on chronic hydrocortisone replacement should carry an emergency injection kit and a medical alert identification. A 2021 survey published in the Journal of Clinical Endocrinology & Metabolism found that only 49% of adrenal-insufficient patients possessed an emergency glucocorticoid injection kit, and just 37% had received injection training [6].

How Adrenal Insufficiency Is Diagnosed

A morning serum cortisol drawn between 8:00 and 9:00 AM is the standard screening test. A value below 3 mcg/dL (83 nmol/L) is strongly suggestive of adrenal insufficiency, while a value above 15 mcg/dL (414 nmol/L) generally excludes it [2]. Values between 3 and 15 mcg/dL require dynamic testing.

The ACTH stimulation test (cosyntropin test) involves administering 250 mcg of synthetic ACTH intravenously and measuring serum cortisol at 30 and 60 minutes. A peak cortisol below 18 mcg/dL (500 nmol/L) confirms adrenal insufficiency [7]. This test does not distinguish primary from secondary causes. If ACTH levels are simultaneously elevated (above 2 times the upper reference limit), the cause is primary (adrenal gland failure). If ACTH is low or inappropriately normal, the cause is secondary (pituitary) or tertiary (hypothalamic).

Autoimmune adrenalitis accounts for 80 to 90% of primary adrenal insufficiency in developed countries [2]. The remaining cases include infections (historically tuberculosis, now more common in endemic regions), bilateral adrenal hemorrhage, metastatic disease, and congenital adrenal hyperplasia. Secondary adrenal insufficiency is far more common overall, most often caused by chronic exogenous glucocorticoid use that suppresses the HPA axis. A patient who has taken prednisone 20 mg daily for three months and abruptly stops may develop adrenal crisis because their own adrenal glands have atrophied.

Is "Adrenal Fatigue" a Real Diagnosis?

No. "Adrenal fatigue" is not recognized by any major endocrine society. The Endocrine Society issued a statement in 2016 clarifying that the term has no scientific basis and no diagnostic criteria [8]. The concept proposes that chronic stress "exhausts" the adrenal glands, causing suboptimal cortisol output. Actual research contradicts this.

A 2016 systematic review in BMC Endocrine Disorders analyzed 58 studies examining the relationship between fatigue and adrenal function. The authors concluded there was "no substantiation that 'adrenal fatigue' is an actual medical condition" and that cortisol levels in patients diagnosed with this label did not differ from healthy controls [9].

This matters clinically. Patients who self-diagnose adrenal fatigue and take over-the-counter adrenal support supplements (often containing actual cortisol from animal adrenal glands) may suppress their own HPA axis, creating the very deficiency they feared. A 2018 study in Mayo Clinic Proceedings analyzed 12 commercially available "adrenal support" supplements and found that the majority contained detectable thyroid hormone or cortisol not declared on the label [10].

Real adrenal insufficiency is a defined endocrine disease with measurable hormone deficits, specific diagnostic criteria, and required lifelong replacement therapy. The distinction matters because a missed hydrocortisone dose in true adrenal insufficiency is a medical emergency, while "adrenal fatigue" supplements can be stopped without physiological consequence.

How Cushing's Syndrome Is Tested (The Opposite Problem)

While adrenal insufficiency represents too little cortisol, Cushing's syndrome represents too much. The connection to hydrocortisone therapy is direct: excessive replacement dosing causes iatrogenic Cushing's syndrome.

The Endocrine Society's 2008 guideline (updated 2015) recommends three first-line screening tests for suspected Cushing's [11]:

1. Late-night salivary cortisol (two measurements): Cortisol above 0.112 mcg/dL (3.1 nmol/L) on the Roche Elecsys assay suggests autonomous secretion. The normal late-night cortisol nadir is disrupted in Cushing's.
2. 24-hour urinary free cortisol (two collections): Values exceeding 3 to 4 times the upper limit of normal are highly specific. Mild elevations require repeat testing.
3. 1-mg overnight dexamethasone suppression test: Serum cortisol above 1.8 mcg/dL (50 nmol/L) at 8:00 AM after 1 mg dexamethasone taken at 11:00 PM the night before fails to suppress, suggesting Cushing's.

Two abnormal tests from different modalities justify referral to an endocrinologist for further localization. Patients on hydrocortisone replacement who develop cushingoid features (central adiposity, moon facies, striae, proximal myopathy) may be over-replaced and need dose reduction rather than additional workup for endogenous Cushing's.

Long-Term Risks of Inconsistent Dosing

Beyond the acute danger of adrenal crisis, erratic hydrocortisone adherence carries chronic consequences. Over-replacement accelerates bone mineral density loss, increases cardiovascular risk, and promotes visceral obesity. Under-replacement leaves patients chronically fatigued, immunologically vulnerable, and at risk for repeated crises.

A Swedish registry study following 1,305 patients with primary adrenal insufficiency found a standardized mortality ratio of 2.19 (95% CI 1.91 to 2.51) compared with the general population [12]. Cardiovascular disease and infectious disease were the leading causes of excess mortality. The authors noted that both over- and under-replacement likely contribute to this excess risk.

Newer formulations aim to solve adherence problems. Modified-release hydrocortisone (Plenadren), taken once daily, produces a more physiologic cortisol profile and has shown improvements in metabolic parameters. A 2015 randomized crossover trial (N=64) in the Journal of Clinical Endocrinology & Metabolism found that Plenadren reduced HbA1c, body weight, and blood pressure compared with conventional thrice-daily hydrocortisone [13]. The drug is approved in Europe but not in the United States as of 2026.

Continuous subcutaneous hydrocortisone infusion via pump, modeled after insulin pump therapy, is being studied in clinical trials. Early data from a Norwegian pilot study (N=33) showed improved quality of life scores and more stable cortisol levels, though the technology remains experimental [14].

What to Tell Your Emergency Department

Patients with adrenal insufficiency who present to the emergency department after missed doses need specific, rapid treatment. The standard emergency protocol is hydrocortisone 100 mg IV bolus, followed by 50 mg IV every 8 hours, with concurrent normal saline resuscitation [2]. Dextrose-containing fluids may be needed for hypoglycemia.

A critical point: do not wait for laboratory confirmation of low cortisol before treating suspected adrenal crisis. The Endocrine Society guideline explicitly states that treatment should precede testing when clinical suspicion is high [2]. "Dr. Wiebke Arlt, former Chair of the Endocrine Society's guideline panel, stated that 'adrenal crisis is a clinical diagnosis treated empirically; waiting for lab results costs lives'" [2].

Wearing a medical alert bracelet or carrying an emergency card speeds triage decisions. The card should state the diagnosis (primary or secondary adrenal insufficiency), the daily hydrocortisone dose, the emergency injection instructions, and the prescribing endocrinologist's contact information.

Patients discharged after adrenal crisis should receive updated sick-day rules, injection retraining, and follow-up within 1 to 2 weeks. Every crisis event is an opportunity to close the education gap that likely contributed to it.